Get notified when TARA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Dilution Per Share to New Investors $1.47 (new) — New investors face immediate and substantial dilution of $1.47 per share, representing about 28% of the assumed offering price.
Protara Therapeutics files to sell up to $100M of common stock in at-the-market offering
Filed May 28, 2026 · ~2 min read
Key Changes
-
high
Protara may sell up to $100 million of common stock from time to time through TD Cowen under a Sales Agreement, at market prices.
The Offering verify on EDGAR → -
high
The assumed offering price is $5.21 per share, based on the March 31, 2026 closing price; actual sale prices will vary.
The Offering verify on EDGAR → -
high
If the full $100 million is sold at $5.21, the company would issue about 19.2 million new shares, bringing total shares outstanding to about 74.2 million.
The Offering verify on EDGAR →
4 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (UEC 10-K) is open in full — no account needed.
Partner
Trade TARA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify